Maro Ohanian, DO

Rare diseases treated or studied

Based on trial PI assignments and publication topics.

• Acute myeloid leukemia and myelodysplastic syndromes related to alkylating agent→
• Acute myeloid leukemia with t(9;22)(q34.1;q11.2)→
• Chronic myeloid leukemia→

Clinical trials (4)

• NCT03589729
• NCT03630991
• NCT02923986
• NCT03136146

Verify independently

• ClinicalTrials.gov PI search for Maro Ohanian
• NPPES NPI registry entry

Other specialists for Acute myeloid leukemia and myelodysplastic syndromes related to alkylating agent

Peers ranked by clinical-trial PI role, publications, and verification quality.

• He Huang
  The First Affiliated Hospital
• Hagop Kantarjian, MD, MD
  M.D. Anderson Cancer Center
  TX
• Global Clinical Leader
  Daiichi Sankyo
• Olivier Hermine, MD
  Assistance Publique - Hôpitaux de Paris
• Naval Daver, MD, MBBS
  M.D. Anderson Cancer Center
  TX
• Farhad Ravandi-Kashani, MD, M.D
  M.D. Anderson Cancer Center
  TX
• Jorge Cortes, MD
  UT MD Anderson Cancer Center
• Tapan M Kadia
  M D Anderson Cancer Center
  Texas

See all specialists for Acute myeloid leukemia and myelodysplastic syndromes related to alkylating agent →